{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:30:03Z","timestamp":1793403003508,"version":"4.5.0"},"reference-count":181,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, amyloid-beta (A\u03b2) aggregation, tau pathology, and chronic neuroinflammation. Among these, neuroinflammation plays a crucial role in exacerbating disease progression, making it an attractive therapeutic target. However, the presence of the blood-brain barrier (BBB) significantly limits the effective delivery of therapeutic agents to the brain, necessitating novel drug delivery strategies. Nanocarrier-based delivery systems have emerged as a promising solution to these challenges, offering targeted drug transport, enhanced BBB penetration, and improved bioavailability while minimizing systemic toxicity. This review explores the current advancements in nanocarrier-mediated drug delivery for AD, focusing on the mechanisms of neuroinflammation, the role of nanocarriers in overcoming the BBB, and their ability to modulate inflammatory pathways. Furthermore, the review discusses preclinical validation strategies and key challenges, including safety concerns, large-scale production limitations, and regulatory hurdles that must be addressed to enable clinical translation. Future perspectives emphasize the integration of nanotechnology with precision medicine, gene therapy, and artificial intelligence to optimize nanocarrier design for individualized AD treatment. By overcoming these obstacles, nanocarriers hold the potential to revolutionize therapeutic approaches for AD and other neurodegenerative diseases.<\/jats:p>","DOI":"10.3389\/fphar.2025.1591438","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:13:02Z","timestamp":1747181582000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Nanocarrier-based targeted drug delivery for Alzheimer\u2019s disease: addressing neuroinflammation and enhancing clinical translation"],"prefix":"10.3389","volume":"16","author":[{"given":"Kang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"121244","DOI":"10.1016\/j.ijpharm.2021.121244","article-title":"Superparamagnetic iron oxide loaded chitosan coated bilosomes for magnetic nose to brain targeting of resveratrol","volume":"610","author":"Abbas","year":"2021","journal-title":"Int. J. Pharm."},{"key":"B2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11307-017-1084-8","article-title":"Ferumoxytol is not retained in kidney allografts in patients undergoing acute rejection","volume":"20","author":"Aghighi","year":"2018","journal-title":"Mol. imaging Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1111\/ejn.16336","article-title":"Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease","volume":"59","author":"Ahmed","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6564585","DOI":"10.1155\/2021\/6564585","article-title":"Blood-brain barrier overview: structural and functional correlation","volume":"2021","author":"Alahmari","year":"2021","journal-title":"Neural plast."},{"key":"B5","doi-asserted-by":"publisher","first-page":"10572","DOI":"10.3390\/ijms231810572","article-title":"Glial cell-mediated neuroinflammation in Alzheimer's disease","volume":"23","author":"Al-Ghraiybah","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/pharmaceutics14040883","article-title":"Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence","volume":"14","author":"Alshawwa","year":"2022","journal-title":"Pharmaceutics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"122167","DOI":"10.1016\/j.ijpharm.2022.122167","article-title":"Transferrin-functionalized liposomes loaded with vitamin VB12 for Alzheimer's disease therapy","volume":"626","author":"Andrade","year":"2022","journal-title":"Int. J. Pharm."},{"key":"B8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/17458080.2022.2134563","article-title":"Impact of administration route on nanocarrier biodistribution in a murine colitis model","volume":"17","author":"Applegate","year":"2022","journal-title":"J. Exp. Nanosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","article-title":"Review on Alzheimer's disease: inhibition of amyloid beta and tau tangle formation","volume":"167","author":"Ashrafian","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: the core pathogenesis and mechanism of Alzheimer's disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1007\/s00210-023-02612-4","article-title":"Ligand-based active targeting strategies for cancer theranostics","volume":"396","author":"Bandyopadhyay","year":"2023","journal-title":"Naunyn-Schmiedeberg's archives Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1523\/JNEUROSCI.1376-23.2023","article-title":"Astrocytes as drivers and disruptors of behavior: new advances in basic mechanisms and therapeutic targeting","volume":"43","author":"Barnett","year":"2023","journal-title":"J. Neurosci. official J. Soc. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 gene editing: new hope for Alzheimer's disease therapeutics","volume":"40","author":"Bhardwaj","year":"2022","journal-title":"J. Adv. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1021\/acsptsci.2c00033","article-title":"Craft of Co-encapsulation in nanomedicine: a struggle to achieve synergy through reciprocity","volume":"5","author":"Bhattacharjee","year":"2022","journal-title":"ACS Pharmacol. and Transl. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"Cd001191","DOI":"10.1002\/14651858.CD001191.pub4","article-title":"Rivastigmine for Alzheimer's disease","volume":"9","author":"Birks","year":"2015","journal-title":"Cochrane database Syst. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"Cd001190","DOI":"10.1002\/14651858.CD001190.pub3","article-title":"Donepezil for dementia due to Alzheimer's disease","volume":"6","author":"Birks","year":"2018","journal-title":"Cochrane database Syst. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.biopsych.2021.05.025","article-title":"Traumatic brain injury and risk of neurodegenerative disorder","volume":"91","author":"Brett","year":"2022","journal-title":"Biol. psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.3791\/2920","article-title":"Morris water maze test for learning and memory deficits in Alzheimer's disease model mice","author":"Bromley-Brits","year":"2011","journal-title":"J. Vis. Exp. JoVE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1039\/d2tb02001g","article-title":"Physicochemical properties, pharmacokinetics, toxicology and application of nanocarriers","volume":"11","author":"Cai","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"B22","doi-asserted-by":"publisher","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","article-title":"Microglia in the neuroinflammatory pathogenesis of Alzheimer's disease and related therapeutic targets","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimer's and dementia J. Alzheimer's Assoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molmed.2018.11.006","article-title":"Astrocyte biomarkers in Alzheimer's disease","volume":"25","author":"Carter","year":"2019","journal-title":"Trends Mol. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3390\/ma14071802","article-title":"Biomaterials for drugs nose-brain transport: a new therapeutic approach for neurological diseases","volume":"14","author":"Cassano","year":"2021","journal-title":"Mater. (Basel, Switz.)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"102131","DOI":"10.1016\/j.omtn.2024.102131","article-title":"Anti-miRNA103\/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage","volume":"35","author":"Cepparulo","year":"2024","journal-title":"Mol. Ther. Nucleic acids"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.4110\/in.2023.23.e23","article-title":"Extracellular acidification augments NLRP3-mediated inflammasome signaling in macrophages","volume":"23","author":"Chae","year":"2023","journal-title":"Immune Netw."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1073\/pnas.0707046105","article-title":"Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","article-title":"Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy","volume":"615","author":"Chen","year":"2023","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/adhm.201400729","article-title":"Traceable self-assembly of laser-triggered cyanine-based micelle for synergistic therapeutic effect","volume":"4","author":"Chen","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"B31","doi-asserted-by":"publisher","first-page":"14954","DOI":"10.3390\/ijms241914954","article-title":"Transferrin-conjugated melittin-loaded L-arginine-coated iron oxide nanoparticles for mitigating beta-amyloid pathology of the 5XFAD mouse brain","volume":"24","author":"Choi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s13346-018-0552-2","article-title":"Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends","volume":"8","author":"Choudhury","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.addr.2016.08.007","article-title":"In vitro toxicity assessment of oral nanocarriers","volume":"106","author":"Ciappellano","year":"2016","journal-title":"Adv. drug Deliv. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.29399\/npa.28275","article-title":"Donepezil-loaded PLGA-b-PEG nanoparticles enhance the learning and memory function of beta-amyloid rat model of Alzheimer's disease","volume":"59","author":"\u00c7\u0131nar","year":"2022","journal-title":"Noro psikiyatri arsivi"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1039\/c9tb01222b","article-title":"Nucleic acids presenting polymer nanomaterials as vaccine adjuvants","volume":"7","author":"Comberlato","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"B36","doi-asserted-by":"publisher","first-page":"17908","DOI":"10.1038\/s41598-022-22963-x","article-title":"Glial cell reactivity and oxidative stress prevention in Alzheimer's disease mice model by an optimized NMDA receptor antagonist","volume":"12","author":"Companys-Alemany","year":"2022","journal-title":"Sci. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/polym12061397","article-title":"Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis","volume":"12","author":"Das","year":"2020","journal-title":"Polymers"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2306081","DOI":"10.1002\/adma.202306081","article-title":"Oral nanomedicine: challenges and opportunities","volume":"36","author":"Deng","year":"2024","journal-title":"Adv. Mater. (Deerf. Beach, Fla)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"118814","DOI":"10.1016\/j.ijpharm.2019.118814","article-title":"Dendrimers in the context of nanomedicine","volume":"573","author":"Dias","year":"2020","journal-title":"Int. J. Pharm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1080\/1061186X.2017.1289541","article-title":"Enhanced blood\u2013brain barrier transport of vinpocetine by oral delivery of mixed micelles in combination with a message guider","volume":"25","author":"Ding","year":"2017","journal-title":"J. Drug Target."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.apsb.2021.11.016","article-title":"The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers","volume":"12","author":"Fan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B42","doi-asserted-by":"publisher","first-page":"113806","DOI":"10.1016\/j.bbr.2022.113806","article-title":"Age-related deficits in working memory in 5xFAD mice in the Hebb-Williams maze","volume":"424","author":"Fertan","year":"2022","journal-title":"Behav. Brain Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7579","DOI":"10.1039\/d2cs00998f","article-title":"'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective","volume":"52","author":"Fu","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"148674","DOI":"10.1016\/j.brainres.2023.148674","article-title":"Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: multiple sclerosis","volume":"1822","author":"Gadhave","year":"2024","journal-title":"Brain Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e2407793","DOI":"10.1002\/adma.202407793","article-title":"Toward the integration of machine learning and molecular modeling for designing drug delivery nanocarriers","volume":"36","author":"Gao","year":"2024","journal-title":"Adv. Mater. (Deerf. Beach, Fla)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"eAO0764","DOI":"10.31744\/einstein_journal\/2024AO0764","article-title":"Assessing the toxicity of one-step-synthesized PEG-coated gold nanoparticles: in vitro and in vivo studies","volume":"22","author":"Garrig\u00f3s","year":"2024","journal-title":"Einstein (Sao Paulo, Braz.)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-021-02263-w","article-title":"Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer's disease","volume":"141","author":"Gerrits","year":"2021","journal-title":"Acta neuropathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jconrel.2019.12.034","article-title":"Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: role of surface engineered nanocarriers","volume":"319","author":"Gopalan","year":"2020","journal-title":"J. Control. release official J. Control. Release Soc."},{"key":"B49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejpb.2016.12.030","article-title":"Dendrimers as nanocarriers for nucleoside analogues","volume":"114","author":"Gorzkiewicz","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12974-020-01819-z","article-title":"A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation","volume":"17","author":"Goshi","year":"2020","journal-title":"J. neuroinflammation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","article-title":"New insights into atypical Alzheimer's disease in the era of biomarkers","volume":"20","author":"Graff-Radford","year":"2021","journal-title":"Lancet Neurology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.addr.2016.06.006","article-title":"Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs","volume":"106","author":"Griffin","year":"2016","journal-title":"Adv. drug Deliv. Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"10646","DOI":"10.1021\/nn3037573","article-title":"Simultaneous diagnosis and gene therapy of immuno-rejection in rat allogeneic heart transplantation model using a T-cell-targeted theranostic nanosystem","volume":"6","author":"Guo","year":"2012","journal-title":"ACS Nano"},{"key":"B54","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimer's and dementia J. Alzheimer's Assoc."},{"key":"B55","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1755-5949.2010.00147.x","article-title":"REVIEW: curcumin and Alzheimer's disease","volume":"16","author":"Hamaguchi","year":"2010","journal-title":"CNS Neurosci. and Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/pharmaceutics7020027","article-title":"Liposomal conjugates for drug delivery to the central nervous system","volume":"7","author":"Helm","year":"2015","journal-title":"Pharmaceutics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neuron.2022.10.021","article-title":"Microglial Piezo1 senses A\u03b2 fibril stiffness to restrict Alzheimer's disease","volume":"111","author":"Hu","year":"","journal-title":"Neuron"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1228679","DOI":"10.3389\/fcell.2023.1228679","article-title":"Recent progress of nanomedicine in the treatment of Alzheimer's disease","volume":"11","author":"Hu","year":"","journal-title":"Front. Cell. Dev. Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"107100","DOI":"10.1016\/j.phrs.2024.107100","article-title":"Novel nano-drug delivery system for natural products and their application","volume":"201","author":"Huang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"0180","DOI":"10.34133\/research.0180","article-title":"Pathological BBB crossing melanin-like nanoparticles as metal-ion chelators and neuroinflammation regulators against Alzheimer's disease","volume":"6","author":"Huang","year":"2023","journal-title":"Res. (Wash. DC)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jphotobiol.2018.11.008","article-title":"A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid \u03b2 aggregation in Alzheimer's disease","volume":"190","author":"Huo","year":"2019","journal-title":"J. Photochem. Photobiol. B, Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jconrel.2023.08.001","article-title":"\u03b2-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models","volume":"361","author":"Israel","year":"2023","journal-title":"J. Control. release official J. Control. Release Soc."},{"key":"B63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12951-020-00746-8","article-title":"Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT\/NIRF imaging of colon cancer","volume":"19","author":"Jing","year":"2021","journal-title":"J. nanobiotechnology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","article-title":"The neuroimmune axis of Alzheimer's disease","volume":"15","author":"Jorfi","year":"2023","journal-title":"Genome Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2217\/nnm-2022-0096","article-title":"Formulation and clinical advancement of nanourchins: a novel multibranched nanoparticulate drug-delivery system","volume":"17","author":"Joshi","year":"2022","journal-title":"Nanomedicine Lond. Engl."},{"key":"B67","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","article-title":"Alzheimer's disease: from immunotherapy to immunoprevention","volume":"186","author":"Jucker","year":"2023","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1208\/s12248-021-00648-z","article-title":"Understanding drug delivery to the brain using liposome-based strategies: studies that provide mechanistic insights are essential","volume":"23","author":"Juhairiyah","year":"2021","journal-title":"AAPS J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12640-020-00258-1","article-title":"Exploring the neuroprotective potential of rosiglitazone embedded nanocarrier system on streptozotocin induced mice model of Alzheimer's disease","volume":"39","author":"K","year":"2021","journal-title":"Neurotox. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1714","DOI":"10.1002\/wnan.1714","article-title":"Protein nanoparticles in molecular, cellular, and tissue imaging","volume":"13","author":"Kaku","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomedicine nanobiotechnology."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1021\/acs.molpharmaceut.5b00222","article-title":"Enhancing glioblastoma-specific penetration by functionalization of nanoparticles with an iron-mimic peptide targeting transferrin\/transferrin receptor complex","volume":"12","author":"Kang","year":"2015","journal-title":"Mol. Pharm."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1002\/med.22064","article-title":"Polymer nanotherapeutics: a promising approach toward microglial inhibition in neurodegenerative diseases","volume":"44","author":"Keshavarz","year":"2024","journal-title":"Med. Res. Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2174\/1567201818666211021160441","article-title":"Toxicity and surface modification of dendrimers: a critical review","volume":"19","author":"Kharwade","year":"2022","journal-title":"Curr. drug Deliv."},{"key":"B74","doi-asserted-by":"publisher","first-page":"102091","DOI":"10.1016\/j.arr.2023.102091","article-title":"Role of diet and exercise in aging, Alzheimer's disease, and other chronic diseases","volume":"91","author":"Khemka","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1399121","DOI":"10.3389\/fphar.2024.1399121","article-title":"Alzheimer's disease and its treatment-yesterday, today, and tomorrow","volume":"15","author":"Kim","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMra0912273","volume":"363","author":"Kim","year":"2010","journal-title":"Nanomedicine. N. Engl. J. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"102347","DOI":"10.1016\/j.redox.2022.102347","article-title":"The antioxidant enzyme Peroxiredoxin-1 controls stroke-associated microglia against acute ischemic stroke","volume":"54","author":"Kim","year":"2022","journal-title":"Redox Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.neubiorev.2020.02.012","article-title":"Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology","volume":"112","author":"Kosel","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B79","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","author":"Kozma","year":"2020","journal-title":"Adv. drug Deliv. Rev."},{"key":"B80","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1021\/acschemneuro.0c00430","article-title":"Biophysical, biochemical, and behavioral implications of ApoE3 conjugated donepezil nanomedicine in a a\u03b2(1-42) induced Alzheimer's disease rat model","volume":"11","author":"Krishna","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e108662","DOI":"10.15252\/embj.2021108662","article-title":"Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer's disease pathology","volume":"40","author":"Kummer","year":"2021","journal-title":"EMBO J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"10031","DOI":"10.1007\/s00210-024-03253-x","article-title":"Auranofin-loaded PLGA nanoparticles alleviate cognitive deficit induced by streptozotocin in rats model: modulation of oxidative stress, neuroinflammatory markers, and neurotransmitters","volume":"397","author":"Kushawaha","year":"2024","journal-title":"Naunyn-Schmiedeberg's archives Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1021\/acs.molpharmaceut.2c00359","article-title":"Development of (68)Ga-labeled hepatitis E virus nanoparticles for targeted drug delivery and diagnostics with PET","volume":"19","author":"Lambidis","year":"2022","journal-title":"Mol. Pharm."},{"key":"B84","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","article-title":"Roles of neuropathology-associated reactive astrocytes: a systematic review","volume":"11","author":"Lawrence","year":"2023","journal-title":"Acta neuropathol. Commun."},{"key":"B85","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tiv.2017.03.007","article-title":"Cytotoxicity and genotoxicity of lipid nanocapsules","volume":"41","author":"Le Roux","year":"2017","journal-title":"Toxicol. vitro Int. J. Publ. Assoc. BIBRA"},{"key":"B87","doi-asserted-by":"publisher","first-page":"101455","DOI":"10.1016\/j.mtbio.2025.101455","article-title":"Doxorubicin-loaded PEGylated liposome modified with ANGPT2-specific peptide for integrative glioma-targeted imaging and therapy","volume":"30","author":"Li","year":"2025","journal-title":"Mater. today Bio"},{"key":"B88","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1039\/d2bm02152h","article-title":"Transferrin receptor 1 targeted nanomedicine for brain tumor therapy","volume":"11","author":"Li","year":"2023","journal-title":"Biomaterials Sci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"937486","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019","volume":"14","author":"Li","year":"2022","journal-title":"Front. aging Neurosci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"45713","DOI":"10.1021\/acsami.3c11098","article-title":"Multimodal imaging-guided strategy for developing (177)Lu-labeled metal-organic framework nanomedicine with potential in cancer therapy","volume":"15","author":"Liang","year":"2023","journal-title":"ACS Appl. Mater. and interfaces"},{"key":"B91","doi-asserted-by":"publisher","first-page":"Cd001747","DOI":"10.1002\/14651858.CD001747.pub4","article-title":"Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment","volume":"11","author":"Lim","year":"2024","journal-title":"Cochrane database Syst. Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1038\/s41467-018-04529-6","article-title":"Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound","volume":"9","author":"Lipsman","year":"2018","journal-title":"Nat. Commun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12974-024-03163-y","article-title":"Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?","volume":"21","author":"Lista","year":"2024","journal-title":"J. neuroinflammation"},{"key":"B94","doi-asserted-by":"publisher","first-page":"101819","DOI":"10.1016\/j.arr.2022.101819","article-title":"Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases","volume":"84","author":"Lista","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1039\/c8cs00618k","article-title":"Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer","volume":"48","author":"Liu","year":"","journal-title":"Chem. Soc. Rev."},{"key":"B96","doi-asserted-by":"publisher","first-page":"102075","DOI":"10.1016\/j.nano.2019.102075","article-title":"Functional lipid polymeric nanoparticles for oral drug delivery: rapid mucus penetration and improved cell entry and cellular transport","volume":"21","author":"Liu","year":"","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/alz.12341","article-title":"Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL-1\u03b2 drives amplified responses in primed astrocytes and neuronal network dysfunction","volume":"17","author":"Lopez-Rodriguez","year":"2021","journal-title":"Alzheimer's and dementia J. Alzheimer's Assoc."},{"key":"B98","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.colsurfb.2016.04.041","article-title":"Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment","volume":"145","author":"Loureiro","year":"2016","journal-title":"Colloids surfaces B, Biointerfaces"},{"key":"B99","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2147\/IJN.S372961","article-title":"Paclitaxel has a reduced toxicity profile in healthy rats after polymeric micellar nanoparticle delivery","volume":"18","author":"Lu","year":"2023","journal-title":"Int. J. nanomedicine"},{"key":"B100","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1515\/revneuro-2021-0092","article-title":"Immune modulations and immunotherapies for Alzheimer's disease: a comprehensive review","volume":"33","author":"Mahdiabadi","year":"2022","journal-title":"Rev. Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/ijms19061637","article-title":"Use of curcumin, a natural polyphenol for targeting molecular pathways in treating age-related neurodegenerative diseases","volume":"19","author":"Maiti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/ijms23020760","article-title":"Nanocarriers for delivery of oligonucleotides to the CNS","volume":"23","author":"Male","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/brain\/awae269","article-title":"Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration","volume":"148","author":"Malpetti","year":"2025","journal-title":"Brain a J. neurology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"102575","DOI":"10.1016\/j.conb.2022.102575","article-title":"How neurons die in Alzheimer's disease: Implications for neuroinflammation","volume":"75","author":"Mangalmurti","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/joa.12563","article-title":"Quantum dots labelling allows detection of the homing of mesenchymal stem cells administered as immunomodulatory therapy in an experimental model of pancreatic islets transplantation","volume":"230","author":"Mannucci","year":"2017","journal-title":"J. Anat."},{"key":"B106","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev-immunol-101921-035222","article-title":"Immune activation in alzheimer disease","volume":"42","author":"Mary","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/14740338.2018.1524870","article-title":"The efficacy and safety of memantine for the treatment of Alzheimer's disease","volume":"17","author":"Matsunaga","year":"2018","journal-title":"Expert Opin. drug Saf."},{"key":"B108","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/17425247.2024.2440618","article-title":"Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes","volume":"22","author":"Mazumdar","year":"2025","journal-title":"Expert Opin. drug Deliv."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JAD-170706","article-title":"Alzheimer's disease can Be spared by nonsteroidal anti-inflammatory drugs","volume":"62","author":"McGeer","year":"2018","journal-title":"J. Alzheimer's Dis. JAD."},{"key":"B110","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-022-05534-y","article-title":"Microglia regulate central nervous system myelin growth and integrity","volume":"613","author":"McNamara","year":"2023","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/IJN.S151474","article-title":"Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease","volume":"13","author":"Meng","year":"2018","journal-title":"Int. J. nanomedicine"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3390\/pharmaceutics15041054","article-title":"Dendrimers and derivatives as multifunctional nanotherapeutics for Alzheimer's disease","volume":"15","author":"Moreira","year":"2023","journal-title":"Pharmaceutics"},{"key":"B113","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/biomedicines10050985","article-title":"Intranasal administration of a TRAIL neutralizing monoclonal antibody adsorbed in PLGA nanoparticles and NLC nanosystems: an in vivo study on a mouse model of Alzheimer's disease","volume":"10","author":"Musumeci","year":"2022","journal-title":"Biomedicines"},{"key":"B114","doi-asserted-by":"publisher","first-page":"114417","DOI":"10.1016\/j.addr.2022.114417","article-title":"Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines","volume":"188","author":"Nakamura","year":"2022","journal-title":"Adv. drug Deliv. Rev."},{"key":"B115","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jconrel.2019.06.026","article-title":"Intravital microscopy reveals a novel mechanism of nanoparticles excretion in kidney","volume":"307","author":"Naumenko","year":"2019","journal-title":"J. Control. release official J. Control. Release Soc."},{"key":"B116","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/ma13020366","article-title":"Drug delivery with polymeric nanocarriers-cellular uptake mechanisms","volume":"13","author":"Nelemans","year":"2020","journal-title":"Mater. (Basel, Switz.)"},{"key":"B117","doi-asserted-by":"publisher","first-page":"12050","DOI":"10.1038\/s41598-018-30487-6","article-title":"IL-1\u03b2, IL-6, TNF- \u03b1 and CRP in elderly patients with depression or Alzheimer's disease: systematic review and meta-analysis","volume":"8","author":"Ng","year":"2018","journal-title":"Sci. Rep."},{"key":"B118","doi-asserted-by":"publisher","first-page":"102363","DOI":"10.1016\/j.redox.2022.102363","article-title":"Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke","volume":"54","author":"Ni","year":"2022","journal-title":"Redox Biol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/biom11020195","article-title":"Epigenetics of Alzheimer's disease","volume":"11","author":"Nikolac Perkovic","year":"2021","journal-title":"Biomolecules"},{"key":"B120","doi-asserted-by":"publisher","first-page":"13121","DOI":"10.1021\/acsnano.2c08275","article-title":"Targeted nanocarriers Co-opting pulmonary intravascular leukocytes for drug delivery to the injured brain","volume":"17","author":"Nong","year":"2023","journal-title":"ACS Nano"},{"key":"B121","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","article-title":"Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain","volume":"348","author":"Ogawa","year":"2022","journal-title":"J. Control. release official J. Control. Release Soc."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.neuron.2022.06.021","article-title":"Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer's disease","volume":"110","author":"Otero-Garcia","year":"2022","journal-title":"Neuron"},{"key":"B123","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jconrel.2015.09.001","article-title":"Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics","volume":"219","author":"Pagels","year":"2015","journal-title":"J. Control. release official J. Control. Release Soc."},{"key":"B124","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/17460441.2023.2293158","article-title":"The SH-SY5Y cell line: a valuable tool for Parkinson's disease drug discovery","volume":"19","author":"Pandey","year":"2024","journal-title":"Expert Opin. drug Discov."},{"key":"B125","doi-asserted-by":"publisher","first-page":"101947","DOI":"10.1016\/j.redox.2021.101947","article-title":"NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases","volume":"41","author":"Park","year":"2021","journal-title":"Redox Biol."},{"key":"B126","first-page":"191","article-title":"Solid lipid nanoparticles for targeted brain drug delivery","volume-title":"Nanotechnology-based targeted drug delivery systems for brain tumors","author":"Patel","year":"2018"},{"key":"B127","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. nanobiotechnology"},{"key":"B128","doi-asserted-by":"publisher","first-page":"122864","DOI":"10.1016\/j.biomaterials.2024.122864","article-title":"Engineered 3D human neurovascular model of Alzheimer's disease to study vascular dysfunction","volume":"314","author":"Pavlou","year":"2025","journal-title":"Biomaterials"},{"key":"B129","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.addr.2020.07.017","article-title":"Nuclear imaging approaches facilitating nanomedicine translation","author":"P\u00e9rez-Medina","year":"2020","journal-title":"Adv. drug Deliv. Rev."},{"key":"B130","doi-asserted-by":"publisher","first-page":"12574","DOI":"10.1039\/d3nr01539d","article-title":"Sonoporation-assisted micelle delivery in subcutaneous glioma-bearing mice evaluated by PET\/fluorescent bi-modal imaging","volume":"15","author":"Porret","year":"2023","journal-title":"Nanoscale"},{"key":"B131","doi-asserted-by":"publisher","first-page":"125168","DOI":"10.1016\/j.ijbiomac.2023.125168","article-title":"Synthesis and characterization of biological macromolecules double emulsion based on carboxymethylcellulose\/gelatin hydrogel incorporated with ZIF-8 as metal organic frameworks for sustained anti-cancer drug release","volume":"243","author":"Pourmadadi","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e140966","DOI":"10.1172\/JCI140966","article-title":"Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging","volume":"131","author":"Propson","year":"2021","journal-title":"J. Clin. investigation"},{"key":"B133","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bcp.2014.01.011","article-title":"Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines","volume":"88","author":"Puzzo","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.2147\/IJN.S374024","article-title":"Selenium nanoparticles-enriched lactobacillus casei ATCC 393 prevents cognitive dysfunction in mice through modulating microbiota-gut-brain Axis","volume":"17","author":"Qiao","year":"2022","journal-title":"Int. J. nanomedicine"},{"key":"B135","doi-asserted-by":"publisher","first-page":"e2000587","DOI":"10.1002\/adhm.202000587","article-title":"Nanobottles for controlled release and drug delivery","volume":"10","author":"Qiu","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"B136","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2174\/1389200221666200508074348","article-title":"Polymeric nanoparticles for brain drug delivery - a review","volume":"21","author":"Raman","year":"2020","journal-title":"Curr. drug Metab."},{"key":"B137","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"B138","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/cpt.1777","article-title":"Model-informed artificial intelligence: reinforcement learning for precision dosing","volume":"107","author":"Ribba","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B139","doi-asserted-by":"publisher","first-page":"102810","DOI":"10.1016\/j.nano.2025.102810","article-title":"Enhanced rivastigmine delivery through nanoemulsion and pyridoxine supplementation: an in-vivo study on Alzheimer's disease intervention","volume":"65","author":"Roy","year":"2025","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.biopha.2018.12.133","article-title":"Applications of nanotechnology in drug delivery to the central nervous system","volume":"111","author":"Saeedi","year":"2019","journal-title":"Biomed. and Pharmacother. = Biomedecine and Pharmacother."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s11948-015-9705-6","article-title":"Defining nano, nanotechnology and nanomedicine: why should it matter?","volume":"22","author":"Satalkar","year":"2016","journal-title":"Sci. Eng. ethics"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet (London, Engl.)"},{"key":"B143","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-231159","article-title":"The neuro-inflammatory microenvironment: an important regulator of stem cell survival in Alzheimer's disease","volume":"98","author":"Shen","year":"2024","journal-title":"J. Alzheimer's Dis. JAD."},{"key":"B144","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","article-title":"A rotarod test for evaluation of motor skill learning","volume":"189","author":"Shiotsuki","year":"2010","journal-title":"J. Neurosci. methods"},{"key":"B145","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S171490","article-title":"PPAR\u03b3 agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies","volume":"13","author":"Silva-Abreu","year":"2018","journal-title":"Int. J. nanomedicine"},{"key":"B146","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. neuroinflammation"},{"key":"B147","doi-asserted-by":"publisher","first-page":"155802","DOI":"10.1016\/j.phymed.2024.155802","article-title":"Zexieyin formula alleviates Alzheimer's disease via post-synaptic CaMKII modulating AMPA receptor: involved in promoting neurogenesis to strengthen synaptic plasticity in mice hippocampus","volume":"131","author":"Sun","year":"2024","journal-title":"Phytomedicine Int. J. phytotherapy Phytopharm."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1016\/j.drudis.2021.06.011","article-title":"Brain safety concerns of nanomedicines: the need for a specific regulatory framework","volume":"26","author":"Szabat-Iriaka","year":"2021","journal-title":"Drug Discov. Today"},{"key":"B149","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12987-025-00641-0","article-title":"PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier","volume":"22","author":"Szecsk\u00f3","year":"2025","journal-title":"Fluids barriers CNS"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.xphs.2023.01.010","article-title":"Machine learning for pharmacokinetic\/pharmacodynamic modeling","volume":"112","author":"Tang","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1021\/acs.langmuir.5b00213","article-title":"Polymer directed self-assembly of pH-responsive antioxidant nanoparticles","volume":"31","author":"Tang","year":"2015","journal-title":"Langmuir ACS J. surfaces colloids"},{"key":"B152","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-023-00649-w","article-title":"Amyloid-\u03b2 (A\u03b2) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice","volume":"18","author":"Taylor","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"B153","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjugate Chem."},{"key":"B154","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"124686","DOI":"10.1016\/j.ijpharm.2024.124686","article-title":"The piper at the gates of brain: a systematic review of surface modification strategies on lipid nanoparticles to overcome the Blood-Brain-Barrier","volume":"665","author":"Vargas","year":"2024","journal-title":"Int. J. Pharm."},{"key":"B156","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3233\/JAD-231337","article-title":"Effects of intranasal dantrolene nanoparticles on brain concentration and behavior in PS19 tau transgenic mice","volume":"98","author":"Vera","year":"2024","journal-title":"J. Alzheimer's Dis. JAD."},{"key":"B157","doi-asserted-by":"publisher","first-page":"e1906861","DOI":"10.1002\/smll.201906861","article-title":"Self-therapeutic nanoparticle that alters tau protein and ameliorates tauopathy toward a functional nanomedicine to tackle Alzheimer's","volume":"16","author":"Vimal","year":"2020","journal-title":"Small (Weinheim der Bergstrasse, Ger.)"},{"key":"B158","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12951-022-01605-4","article-title":"Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery","volume":"20","author":"Waheed","year":"2022","journal-title":"J. nanobiotechnology"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","article-title":"Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia","volume":"109","author":"Wang","year":"","journal-title":"Neuron"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1117172","DOI":"10.3389\/fimmu.2023.1117172","article-title":"The effects of microglia-associated neuroinflammation on Alzheimer's disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"125450","DOI":"10.1016\/j.ijpharm.2025.125450","article-title":"Personalized Nanomedicine-Mediated immune regulation for Anti-Rejection in organ transplantation","volume":"674","author":"Wang","year":"2025","journal-title":"Int. J. Pharm."},{"key":"B162","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jconrel.2020.08.045","article-title":"Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration","volume":"331","author":"Wang","year":"","journal-title":"J. Control. release official J. Control. Release Soc."},{"key":"B163","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jconrel.2018.04.034","article-title":"Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease","volume":"279","author":"Wang","year":"2018","journal-title":"J. Control. release official J. Control. Release Soc."},{"key":"B164","doi-asserted-by":"publisher","first-page":"23223","DOI":"10.1021\/acsnano.3c06019","article-title":"Stimuli-responsive polymer-based nanosystems for cancer theranostics","volume":"17","author":"Wei","year":"2023","journal-title":"ACS Nano"},{"key":"B165","doi-asserted-by":"publisher","first-page":"114895","DOI":"10.1016\/j.addr.2023.114895","article-title":"Stealth and pseudo-stealth nanocarriers","volume":"198","author":"Wen","year":"2023","journal-title":"Adv. drug Deliv. Rev."},{"key":"B166","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1176\/appi.focus.20106","article-title":"Review of current strategies for delivering Alzheimer's disease drugs across the blood-brain barrier","volume":"20","author":"Wong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B168","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1007\/s12274-015-0750-x","article-title":"Electrically pulsatile responsive drug delivery platform for treatment of Alzheimer\u2019s disease","volume":"8","author":"Wu","year":"2015","journal-title":"Nano Res."},{"key":"B169","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3233\/JAD-230199","article-title":"Microglia-Astrocyte communication in Alzheimer's disease","volume":"95","author":"Wu","year":"2023","journal-title":"J. Alzheimer's Dis. JAD."},{"key":"B170","doi-asserted-by":"publisher","first-page":"122749","DOI":"10.1016\/j.biomaterials.2024.122749","article-title":"Highly BBB-permeable nanomedicine reverses neuroapoptosis and neuroinflammation to treat Alzheimer's disease","volume":"312","author":"Xie","year":"2025","journal-title":"Biomaterials"},{"key":"B171","doi-asserted-by":"publisher","first-page":"119491","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"key":"B172","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1021\/acs.biomac.3c00134","article-title":"A novel NQO1 enzyme-responsive polyurethane nanocarrier for redox-triggered intracellular drug release","volume":"24","author":"Xie","year":"2023","journal-title":"Biomacromolecules"},{"key":"B173","doi-asserted-by":"publisher","first-page":"e2203182","DOI":"10.1002\/smll.202203182","article-title":"Intranasal delivery of BACE1 siRNA and rapamycin by dual targets modified nanoparticles for Alzheimer's disease therapy","volume":"18","author":"Yang","year":"","journal-title":"Small (Weinheim der Bergstrasse, Ger.)"},{"key":"B174","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41467-021-27572-2","article-title":"Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease","volume":"13","author":"Yang","year":"","journal-title":"Nat. Commun."},{"key":"B175","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1039\/d1tb01290h","article-title":"A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer's disease management by repairing and promoting neuron regeneration","volume":"9","author":"Yuan","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"B176","doi-asserted-by":"publisher","first-page":"12168","DOI":"10.1021\/acsomega.1c00867","article-title":"Encapsulation of curcumin in polystyrene-based nanoparticles-drug loading capacity and cytotoxicity","volume":"6","author":"Zatorska-P\u0142achta","year":"2021","journal-title":"ACS omega"},{"key":"B177","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"key":"B178","doi-asserted-by":"publisher","first-page":"121690","DOI":"10.1016\/j.biomaterials.2022.121690","article-title":"Blood-brain barrier Permeable nanoparticles for Alzheimer's disease treatment by selective mitophagy of microglia","volume":"288","author":"Zhong","year":"2022","journal-title":"Biomaterials"},{"key":"B179","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J. Control. release official J. Control. Release Soc."},{"key":"B180","doi-asserted-by":"publisher","first-page":"683935","DOI":"10.3389\/fphar.2021.683935","article-title":"Nanoparticles: a hope for the treatment of inflammation in CNS","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/biom9120790","article-title":"Dendrimer-based drug delivery systems for brain targeting","volume":"9","author":"Zhu","year":"2019","journal-title":"Biomolecules"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1591438\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:13:03Z","timestamp":1747181583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1591438\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":181,"alternative-id":["10.3389\/fphar.2025.1591438"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1591438","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"article-number":"1591438"}}